ATE154387T1 - Cdna für ratten c-typ natriuretisches peptid und vorläuferprotein - Google Patents

Cdna für ratten c-typ natriuretisches peptid und vorläuferprotein

Info

Publication number
ATE154387T1
ATE154387T1 AT91115393T AT91115393T ATE154387T1 AT E154387 T1 ATE154387 T1 AT E154387T1 AT 91115393 T AT91115393 T AT 91115393T AT 91115393 T AT91115393 T AT 91115393T AT E154387 T1 ATE154387 T1 AT E154387T1
Authority
AT
Austria
Prior art keywords
cdna
precursor protein
rats
type natriuretic
natriuretic peptide
Prior art date
Application number
AT91115393T
Other languages
English (en)
Inventor
Hisayuki Matsuo
Masayasu Kojima
Kenji Kangawa
Naoto Minamino
Original Assignee
Suntory Ltd
Hisayuki Matsuo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd, Hisayuki Matsuo filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE154387T1 publication Critical patent/ATE154387T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT91115393T 1990-09-11 1991-09-11 Cdna für ratten c-typ natriuretisches peptid und vorläuferprotein ATE154387T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02241074A JP3026352B2 (ja) 1990-09-11 1990-09-11 ラットＣＮＰｃＤＮＡ及び前駆体蛋白

Publications (1)

Publication Number Publication Date
ATE154387T1 true ATE154387T1 (de) 1997-06-15

Family

ID=17068911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91115393T ATE154387T1 (de) 1990-09-11 1991-09-11 Cdna für ratten c-typ natriuretisches peptid und vorläuferprotein

Country Status (8)

Country Link
US (1) US5973134A (de)
EP (1) EP0475394B1 (de)
JP (1) JP3026352B2 (de)
AT (1) ATE154387T1 (de)
DE (1) DE69126487T2 (de)
DK (1) DK0475394T3 (de)
ES (1) ES2104639T3 (de)
GR (1) GR3024580T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
KR20070007842A (ko) 2004-03-31 2007-01-16 카즈와 나카오 신장증가용 조성물
ES2465141T3 (es) 2004-03-31 2014-06-05 Kazuwa Nakao Remedio o medicamento preventivo para la artritis
PL1759001T3 (pl) 2004-04-21 2011-09-30 Alexion Pharma Inc Koniugaty dostarczane do kości i sposób ich zastosowania do nakierowywania białek do kości
JP6055779B2 (ja) 2010-12-27 2016-12-27 アレクシオン ファーマシューティカルズ， インコーポレイテッド ナトリウム利尿ペプチドを含む組成物およびその使用方法
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
JP6787894B2 (ja) 2014-12-05 2020-11-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド 組換えアルカリホスファターゼを用いた発作の処置
CA2973883A1 (en) 2015-01-28 2016-08-04 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
JP6993961B2 (ja) 2015-08-17 2022-01-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼの製造
EP3355904A4 (de) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie
EP3368062A4 (de) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von craniosynostose bei einem patienten
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
KR20180125979A (ko) 2016-04-01 2018-11-26 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
KR20190129058A (ko) 2017-03-31 2019-11-19 알렉시온 파마슈티칼스, 인코포레이티드 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
WO2020033867A2 (en) 2018-08-10 2020-02-13 Alexion Pharmaceuticals, Inc. Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
CA3161266A1 (en) 2019-12-09 2021-06-17 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
US12611447B2 (en) 2020-09-04 2026-04-28 Alexion Pharmaceuticals, Inc. Methods for treating bone mineralization disorders
AU2022218782B2 (en) 2021-02-12 2026-06-25 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3026351B2 (ja) * 1990-07-13 2000-03-27 壽之 松尾 ブタｃｎｐ遺伝子及び前駆体蛋白

Also Published As

Publication number Publication date
GR3024580T3 (en) 1997-12-31
JP3026352B2 (ja) 2000-03-27
ES2104639T3 (es) 1997-10-16
EP0475394B1 (de) 1997-06-11
EP0475394A2 (de) 1992-03-18
DE69126487T2 (de) 1997-11-27
DE69126487D1 (de) 1997-07-17
JPH04121190A (ja) 1992-04-22
DK0475394T3 (da) 1997-07-07
EP0475394A3 (en) 1992-09-16
US5973134A (en) 1999-10-26

Similar Documents

Publication Publication Date Title
DE69126487D1 (de) cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
DK0466175T3 (da) Porcint CNP-gen og præcursor-protein
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
AU6286986A (en) Peptide analogues of mammalian insulin-like growth factor-1
ATE219103T1 (de) Cnp-analoge peptide und ihre verwendung
ATE68503T1 (de) Atriale peptide.
ATE458054T1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
DE69735580D1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma-zeine, und diese exprimierende pflanzen
DK0859785T3 (da) Cycliske peptidanaloge af somatostatin
EP0334244A3 (de) Peptide-Antagonisten von Bradykinin
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
DK0437556T3 (da) Substitutionsanaloger af magaininpeptider
ES2044928T3 (es) Enzima alfa-amidante en terminal c y procedimiento para la produccion y el uso del mismo.
EP0687685A4 (de) Physiologisch-aktive peptide
DE69932804D1 (de) Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung
ATE46173T1 (de) Pharmakologisch aktive peptide.
EP0266006A3 (de) Blutdrucksenkende, diuretische Peptide
GB2361923A (en) Novel protein
DK0570244T3 (da) Fremgangsmåde til fremstilling af peptider, der har et C-terminalt prolinamid
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
RU98109238A (ru) Пептиды с контринсулярным действием

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee